Peter A. Cohen

6.7k citations
85 papers · 5.0k · 1 hit paper · h-index 39

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer
    • T-cell and B-cell Immunology
    • Immune Response and Inflammation
  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Immunotherapy and Immune Responses 55
    • Immune Cell Function and Interaction 20
    • T-cell and B-cell Immunology 19
    • Immune cells in cancer 9
    • Immune Response and Inflammation 9
    • CAR-T cell therapy research 20
    • Cancer Immunotherapy and Biomarkers 18

Peter A. Cohen

83 papers receiving 4.9k citations

Peter A. Cohen's Hit Papers

Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients 2009 · 690 citations
6900+5+11Years since publication200400600

Peers

Peter A. Cohen
Comparison fields: 5 of 142
  • Immunology 3.3k
  • Oncology 1.8k
  • Molecular Biology 1.5k
  • Cancer Research 281
  • Biotechnology 127
Replace Robert A. Kirken with:
Robert A. Kirken United States
Shinsuke Iida Japan
Elaine M. Hurt United States
Shawn G. Clouthier United States
Annette R. Khaled United States
Hiro Wakasugi Japan
James H. Finke United States
Thorsten Hagemann United Kingdom
Lyudmila G. Burdelya United States
Juan M. Zapata United States
Peter A. Cohen relative to Robert A. Kirken United States Robert A. Kirken's profile →
Citations per field
00.5×3.0×
Robert A. Kirken · 1×
Citations per year

Countries citing papers authored by Peter A. Cohen

Since Specialization
Citations

This map shows the geographic impact of Peter A. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Cohen more than expected).

Fields of papers citing papers by Peter A. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Cohen. The network helps show where Peter A. Cohen may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter A. Cohen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter A. Cohen Line = papers co-authored together Peter A. Cohen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Hit paper breakdown →
2009690
2 2000358
3 2011263
4 2011228
5 2010224
6 1999180
7 2016151
8 2003139
9 2003116
10 2008111
11 2010111
12 2004102
13 200098
14 200095
15 199493
16 199976
17 201770
18 200269
19 200068
20 201265

About Peter A. Cohen

Peter A. Cohen is a scholar working on Immunology, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Ecology, Evolution, Behavior and Systematics, having authored 85 papers that have together received 5.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (55 papers), Immune Cell Function and Interaction (20 papers), CAR-T cell therapy research (20 papers), T-cell and B-cell Immunology (19 papers), Cancer Immunotherapy and Biomarkers (18 papers), Immune cells in cancer (9 papers), Immune Response and Inflammation (9 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Immunology (3.3k citations), Oncology (1.8k citations), Molecular Biology (1.5k citations), Cancer Research (281 citations) and Biotechnology (127 citations). Peter A. Cohen has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include James H. Finke, Jennifer S. Ko, Gary K. Koski, Brian I. Rini, Suyu Shu, Joanna Ireland, Patricia Rayman, Brian J. Czerniecki, Shuwen Xu and Sandra Gendler. Their work appears in journals such as The Journal of Immunology, Critical Reviews in Immunology, Blood, Clinical Cancer Research and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact